Siemens Healthineers Weighs Sale, Carve-Out of Diagnostics Unit, Bloomberg Reports
--Siemens Healthineers is considering strategic options for its diagnostics business, which could be valued at up to $8 billion, with a sale or carve-out among the scenarios being considered, Bloomberg reports, citing unnamed sources.
--The review, which seeks to streamline the German healthcare group's operations, is at an early stage and the company could still opt to keep the assets, but the business would likely attract interest from private-equity groups, according to Bloomberg.
--Siemens Healthineers didn't respond to a request for comment when contacted by Dow Jones Newswires.
Full story: https://shorturl.at/fkpsA
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
November 03, 2023 03:41 ET (07:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
US Tariffs On Chinese EVs Do Not Change Our View of US EV Adoption
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth